Current mechanism studies demonstrated that MLT could ameliorate IDD through the inhibition of M1 polarization of Mφs via the SIRT1/Notch signaling pathway, providing the novel evidence to utilize the clinical management of IDD with MLT. The gene discussed is SIRT1; the disease is intervertebral disk degenerative disorder.